Objective: To “measure the beneficial effects of continuous testosterone therapy, delivered by subcutaneous implant, in the relief of somatic, psychological and urogenital symptoms in both pre- and post-menopausal patients, utilizing the validated Health Related Quality of Life (HRQOL), Menopause Rating Scale (MRS).”
300 women pre- and postmenopausal w/ symptoms of androgen deficiency
Each woman to self-administer the MRS at baseline and at 3 months post-insertion.
Conclusion: Continuous testosterone alone, delivered by subcutaneous implant, is effective for the relief of hormone deficiency symptoms in both pre- and postmenopausal women.
To read the complete study please click HERE
Glaser, R., York, A. E., & Dimitrakakis, C. (2011). Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas, 68(4), 355–361. https://doi.org/10.1016/j.maturitas.2010.12.001